Suivi de la qualité bactériologique des eaux de surface (rivière Nahr Ibrahim, Liban)

Le bassin versant du Narh Ibrahim est classé parmi les sites du patrimoine mondial. Les rejets sauvages solides et liquides ont un impact important sur le développement d’une contamination bactériologique tout au long de la rivière. Dans cette étude, des paramètres physico-chimiques et bactériologiques ont été suivis sur neuf sites de prélèvement qui couvrent la rivière Nahr Ibrahim de son amont jusqu’à son estuaire. L’ensemble des paramètres est étudié pendant des périodes de l’année caractérisées par un temps sec ou un temps de crue. Au cours de ces périodes, ces paramètres ont révélé une influence importante du type d’occupation des sols et des phénomènes de lessivage sur la composition bactériologique de la rivière. L’origine et le degré de la contamination bactérienne instantanée ont été également identifiés. Une approche statistique multivariée a montré que l’effet de la localisation du site masque l’effet date sur un même site et pendant la même période. Les sites en aval de la rivière sont caractérisés par une pollution en nitrate et une contamination bactériologique alors que les sites en amont sont marqués par une contamination bactériologique seulement.The Nahr Ibrahim catchment area is classified as an international heritage site. Along the Nahr Ibrahim River, solid and liquid effluents have an important impact on bacterial contamination. Physico-chemical and bacteriological parameters were studied at nine sampling sites located along the Nahr Ibrahim River from its source to its estuary. Total bacteria, total coliforms, fecal coliforms and fecal streptococci were studied during dry and wet weather periods. During these periods, the studied parameters revealed an important influence of the type of soil and leaching on the bacteriological composition of the river. Furthermore, the origin and the degree of temporary bacteriological contamination were identified. A multivariate statistical approach demonstrated that the effect of site location masked the effect of sampling date on the degree of bacteriological contamination. Downstream river sites were characterized by nitrate and bacterial pollution whereas upstream sites showed only by bacterial contamination

Pregnancy outcome in thoracic aortic disease data from the Registry of Pregnancy and Cardiac disease

Background: Cardiovascular disease is the leading cause of death during pregnancy with thoracic aortic dissection being one of the main causes. Thoracic aortic disease is commonly related to hereditary disorders and congenital heart malformations such as bicuspid aortic valve (BAV). Pregnancy is considered a high risk period in women with underlying aortopathy. Methods: The ESC EORP Registry Of Pregnancy And Cardiac disease (ROPAC) is a prospective global registry that enrolled 5739 women with pre-existing cardiac disease. With this analysis, we aim to study the maternal and fetal outcome of pregnancy in women with thoracic aortic disease. Results: Thoracic aortic disease was reported in 189 women (3.3%). Half of them were patients with Marfan syndrome (MFS), 26% had a BAV, 8% Turner syndrome, 2% vascular Ehlers-Danlos syndrome and 11% had no underlying genetic defect or associated congenital heart defect. Aortic dilatation was reported in 58% of patients and 6% had a history of aortic dissection. Four patients, of whom three were patients with MFS, had an acute aortic dissection (three type A and one type B aortic dissection) without maternal or fetal mortality. No complications occurred in women with a history of aortic dissection. There was no significant difference in median fetal birth weight if treated with a beta-blocker or not (2960 g (2358-3390 g) vs 3270 g (2750-3570 g), p value 0.25). Conclusion: This ancillary analysis provides the largest prospective data review on pregnancy risk for patients with thoracic aortic disease. Overall pregnancy outcomes in women with thoracic aortic disease followed according to current guidelines are good

Synthetic Seleno-Glutaredoxin 3 Analogues Are Highly Reducing Oxidoreductases with Enhanced Catalytic Efficiency

BackgroundMalignant pleural mesothelioma (MPM) is a highly lethal malignancy in need for new treatment options. Although immunotherapies have been shown to boost a tumor-specific immune response, not all patients respond and prognostic biomarkers are scarce. In this study, we determined the peripheral blood T cell receptor β (TCRβ) chain repertoire of nine MPM patients before and 5 weeks after the start of dendritic cell (DC)-based immunotherapy.Materials and methodsWe separately profiled PD1+ and PD1−CD4+ and CD8+ T cells, as well as Tregs and analyzed 70 000 TCRβ sequences per patient.ResultsStrikingly, limited TCRβ repertoire diversity and high average clone sizes in total CD3+ T cells before the start of immunotherapy were associated with a better clinical response. To explore the differences in TCRβ repertoire prior-DC-therapy and post-DC-therapy, for each patient the TCRβ clones present in the total CD3+ T cell fractions were classified into five categories, based on therapy-associated frequency changes: expanding, decreasing, stable, newly appearing and disappearing clones. Subsequently, the presence of these five groups of clones was analyzed in the individual sorted T cell fractions. DC-therapy primarily induced TCRβ repertoire changes in the PD1+CD4+ and PD1+CD8+ T cell fractions. In particular, in the PD1+CD8+ T cell subpopulation we found high frequencies of expanding, decreasing and newly appearing clones. Conversion from a PD1− to a PD1+ phenotype was significantly more frequent in CD8+ T cells than in CD4+ T cells. Hereby, the number of expanding PD1+CD8+ T cell clones—and not expanding PD1+CD4+ T cell clones following immunotherapy positively correlated with overall survival, progression-free survival and reduction of tumor volume.ConclusionWe conclude that the clinical response to DC-mediated immunotherapy is dependent on both the pre-existing TCRβ repertoire of total CD3+ T cells and on therapy-induced changes, in particular expanding PD1+CD8+ T cell clones. Therefore, TCRβ repertoire profiling in sorted T cell subsets could serve as predictive biomarker for the selection of MPM patients that benefit from immunotherapy.Trial registration numberNCT02395679